NYSE · TRU

TransUnion

$85.86 +$9.34 (+12.21%) 1D Market open
Session Pulse Regular session chatter is louder than usual 1 mentions today 1 SEC filing since Mon close 8-K its sector ranked 9/11 this week Full pulse →

Key Metrics

$14.75B
Market cap
20.94×
P/E · TTM
$4.73B
Revenue · TTM
$704.40M
Net income
EPS · TTM $3.57
Dividend yield 0.6%
Free cash flow $696.50M
Beta · 1Y 1.03
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    A material event was filed (Form 8-K).

    8-K - TransUnion (0001552033) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 3
    The stock moved -12.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$14.75B
Enterprise value$19.63B
Shares outstanding192.8M
52-wk range$63.37 – $99.39
Avg volume · 20D1.7M
Net cash −$4.87B
Book value / share$24.09
IndustryServices-Consumer Credit Reporting, Collection Agencies
ExchangeNYSE
About TransUnion
IPO dateJun 25, 2015
Employees13500

TransUnion, along with Equifax and Experian, is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E20.94
P/S3.12
P/FCF21.18
EV/EBITDA
EV/Sales4.15
Graham №$43.99

Profitability

Gross
Operating 18.6%
Net 14.9%
FCF 14.7%
ROE / ROIC 15.7% · 7.5%

Financial Health

Current ratio1.93
Quick ratio
Debt / equity1.18
Debt / EBITDA
Net cash −$4.87B
Working capital$971.60M

Cash Flow · TTM

Operating CF $1.02B
Capex −$322.80M
Free cash flow $696.50M
Buybacks $308.70M
Dividends paid $92.90M
Shareholder yield 2.7%

Piotroski F-Score

7 / 9
Strong fundamentals · 7 of 9 signals passing

Altman Z-Score

2.3
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$43.99 vs $77.24
Trades 1.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings